USPTO serial 79427609
ACOERELA
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- KERTGATE, AMY L
- Law office
- TMO LAW OFFICE 113
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with ACOERELA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents for scientific purposes being reagents used for the detection of lipid bilayer membranes in cells and tissue, other than for medical or veterinary purposes; cell culture reagents for scientific and research use; cell culture reagents for scientific or research purposes; chemical diagnostic reagents for industrial use; chemical diagnostic reagents for scientific use; chemical reagent mixtures in kit form, other than for medical or veterinary use; chemical reagents for laboratory use, other than for medical or veterinary use; chemical reagents for scientific purposes; chemical reagents for use in analytical tests, other than for medical or veterinary use; chemical reagents for use in science, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purpose; chemical reagents, other than for medical or veterinary purposes; chemical test reagents, other than for medical or veterinary use; diagnostic reagents and preparations, except for medical or veterinary use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific or research use; diagnostic reagents for scientific purposes; diagnostic reagents for scientific use; diagnostic testing reagents being reagents for testing lipid bilayer membranes; immunoassay reagents, other than for medical use; in vitro diagnostic reagents for scientific purposes; in-vivo diagnostic reagents for scientific use; laboratory reagents for scientific use; monoclonal antibody reagents for scientific purposes; nucleic acid amplification reagents for scientific purposes; reagents for analytical purposes, other than for medical or veterinary purposes; reagents for in-vitro laboratory use, other than for medical or veterinary purposes; reagents for laboratory purposes, other than for medical or veterinary purposes; reagents for medical research; reagents for microbiological analysis, other than for medical or veterinary purposes; reagents for protein folding, other than for medical or veterinary purposes; reagents for research purposes; reagents for scientific or medical research use; reagents for scientific purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; reagents for testing aqueous solutions, other than for medical or veterinary purposes; reagents for testing water, other than for medical or veterinary use; chemical reagents for use in analysis, other than for medical or veterinary purposes; chemical reagents for use in analytical tests, other than for medical or veterinary purposes; reagents for use in biological processing for scientific use, other than for medical or veterinary purposes; chemical reagents for use in diagnostic tests, other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; reagents used for analytical moisture determinations; chemical test reagents, other than for medical use; universal reagents for automated test systems for scientific purposes. | ACTIVE | — |
| 005 | Biological reagents for medical or veterinary purposes; biological reagents for medical purposes; biological reagents for medical use; biological reagents for veterinary purposes; biological reagents for veterinary use; chemical diagnostic reagents for medical use; chemical reagent mixtures for medical or veterinary use; chemical reagent mixtures in kit form for medical or veterinary use; chemical reagents for identification of microorganisms for medical or veterinary use; chemical reagents for laboratory use for medical or veterinary purposes; chemical reagents for medical or veterinary purposes; chemical reagents for medical purposes; chemical reagents for medical use; chemical reagents for pharmaceutical use; chemical reagents for use in medical or veterinary diagnosis being diagnostic chemical reagents for medical or veterinary purposes; chemical reagents for use in medicine; chemical reagents for veterinary purposes; chemical reagents for veterinary use; chemical test reagents for medical use; chemical test reagents for veterinary use; clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic kits comprised of medical diagnostic reagents, preparation and substances for medical purposes; diagnostic kits comprising primarily monoclonal antibodies, buffers and reagents for use in disease testing; diagnostic reagents and assays for detecting antigens for medical purposes; diagnostic reagents and assays for detecting viruses for medical purposes; diagnostic reagents for medical purposes; diagnostic reagents for medical use; diagnostic reagents for medical use, sold in kit form; diagnostic reagents for medicinal use; diagnostic reagents for veterinary purposes; diagnostic reagents for veterinary use; diagnostic test reagents for medical purposes; diagnostic test reagents for veterinary purposes; diagnostic testing reagents for medical purposes; diagnostic testing reagents for veterinary purposes; immunoassay reagents for medical use; in vitro diagnostic reagents for medical purposes; insemination result control diagnosis reagents for veterinary use; in-vivo diagnostic reagents for medical use; laboratory reagents for medical use; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; monoclonal antibody reagents for medical use; nucleic acid amplification reagents for medical use; reagents for analytical purposes for medical use; reagents for analytical purposes for veterinary use; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for medical diagnostic applications being diagnostic reagents for medical use; reagents for medical purposes; reagents for medical use; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for protein folding for medical purposes; reagents for protein folding for veterinary purposes; reagents for testing aqueous solutions for medical purposes; reagents for testing aqueous solutions for veterinary purposes; reagents for use in analysis for medical purposes; reagents for use in analysis for veterinary purposes; reagents for use in analytical tests for medical purposes; reagents for use in analytical tests for veterinary purposes; reagents for use in biological processing for medical purposes; reagents for use in biological processing for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for use in medical diagnosis; reagents for use in the development of monoclonal antibodies for medical purposes; reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA) for medical purposes; test reagents for medical diagnosis; diagnostic test reagents for medical use; diagnostic testing reagents for medical use in detecting lipid bilayer membranes; universal reagents for automated test systems for medical purposes; veterinary diagnostic reagents. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 31, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 31, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 31, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 27, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 27, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 23, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 23, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 23, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 23, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 23, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 23, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 23, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 23, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 23, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 2, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 13, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 13, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 11, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 10, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 2, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 2, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 10, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |